Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back
Main Session

EDU 12 - Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era

The Med Onc Perspective - Biomarkers and Precision Systemic Therapy

Sunday, September 29, 2024
4:47 PM – 5:02 PM ET
Location: Room 146

Learning Objectives:

  1. Recognize the relevant roles of biomarker testing, novel therapeutics and precision surgery/radiotherapy in the management of stage III NSCLC.
  2. Recognize the difference in the meaning of resectability and operability, as it relates to stage III NSCLC.
  3. Review the continued role of radiotherapy in the curative management of stage III NSCLC, including neoadjuvant/adjuvant and definitive strategies.